Announcement - NCCRED Capacity Building and Seed Funding Grants
The National Centre for Clinical Research on Emerging Drugs (NCCRED), formed by a consortium between NDARC, NCETA, NDRI, and St Vincent’s Health Australia has announced the first round of funding grants for innovative clinical research for the treatment of substance use disorders due to methamphetamine or emerging drugs of concern.
Two types of funding grants are currently available:
Capacity building grants – to provide financial support as a value-add to currently established investigator-initiated clinical trials focusing on proposals investigating treatment options for methamphetamine use disorder.
Seed funding grants – to establish investigator-initiated clinical trials / treatment research investigating treatment options for substance use disorders due to methamphetamine or emerging drugs of concern.
Applications of $5,000 to $100,000 will be considered. For more information on applying for the above grants, please email NCCRED at email@example.com.
NCCRED are also offering mentorship to intending applicants to assist them conceptualise their project or develop their funding application. To find out more about the mentorship program contact NCCRED at firstname.lastname@example.org.
Applications for both types of funding grants close on 28 October 2018. Applications will be reviewed the NCCRED Methamphetamine and Emerging Drugs Working Group and successful applicants will be notified by mid-December 2018.
To stay informed about NCCRED, get involved in their activities, or to get updates about future funding rounds, please email the Centre at email@example.com.